Ascentage Pharma Group International (AAPG) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Ascentage Pharma Group In...

NASDAQ: AAPG · Real-Time Price · USD
42.47
1.34 (3.25%)
At close: Aug 29, 2025, 3:59 PM
43.28
1.91%
After-hours: Aug 29, 2025, 06:34 PM EDT

Ascentage Pharma International Cash Flow Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-405.43M -382.86M -360.28M -441.79M -523.29M -261.64M
Depreciation & Amortization
93.17M 94.05M 94.93M 71.28M 47.62M 23.81M
Stock-Based Compensation
20.92M 21.45M 21.98M 17.62M 13.25M 6.63M
Other Working Capital
15.04M 22.14M 29.24M 29.24M 29.24M 14.62M
Other Non-Cash Items
92.62M -153.5M -399.62M -112.91M 173.81M 86.91M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
87.36M 9.17M -69.01M -69.01M -69.01M -34.51M
Operating Cash Flow
-111.36M -411.68M -712M -534.81M -357.61M -178.81M
Capital Expenditures
-24.29M -26.47M -28.66M -20.39M -12.13M -6.07M
Cash Acquisitions
-9.52M -14.76M -20M -20M -20M -10M
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-328.23M -162.08M 4.08M 61.45M 118.83M 59.41M
Investing Cash Flow
-362.03M -203.31M -44.58M 21.06M 86.7M 43.35M
Debt Repayment
n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
-1.96M -4.92M -7.88M -6.9M -5.92M -2.96M
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
316.73M 317.32M 317.91M 118.47M -80.96M -40.48M
Financial Cash Flow
314.77M 312.4M 310.02M 111.57M -86.88M -43.44M
Net Cash Flow
n/a n/a -1.39B -1.39B -1.39B -1.39B
Free Cash Flow
-135.64M -438.15M -740.66M -555.2M -369.75M -184.87M